Overexpression of cyclin D1 in epithelial ovarian cancers
- PMID: 9038263
- DOI: 10.1006/gyno.1996.4569
Overexpression of cyclin D1 in epithelial ovarian cancers
Abstract
Amplification and overexpression of the cell cycle-related gene cyclin D1 have been demonstrated in several human malignancies and have been shown to be directly oncogenic in breast epithelium and lymphocytes. Overexpression of the gene can occur in the absence of gene amplification. We have investigated whether cyclin D1 is overexpressed in a panel of 43 sporadic epithelial ovarian cancers using immunohistochemistry. Cyclin D1 was overexpressed in 26% of these tumors. Overexpression of cyclin D1 is associated with borderline or well-differentiated, grade 1 tumors but does not correlate with a particular histological type, overexpression of the c-erb-B2 oncogene, or presence of estrogen receptors. It is suggested that overexpression of cyclin D1 may contribute to the pathogenesis of epithelial ovarian cancers, including a subset of tumors different from those overexpressing the c-erb-B2 oncogene.
Comment in
-
Discoveries in the cell cycle and ovarian cancer.Gynecol Oncol. 1997 Feb;64(2):187-8. doi: 10.1006/gyno.1997.4611. Gynecol Oncol. 1997. PMID: 9038262 No abstract available.
Similar articles
-
Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.Biochem Biophys Res Commun. 1993 Oct 29;196(2):1010-6. doi: 10.1006/bbrc.1993.2350. Biochem Biophys Res Commun. 1993. PMID: 8240318
-
Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.Mod Pathol. 1995 Jun;8(5):560-7. Mod Pathol. 1995. PMID: 7675778
-
Overexpression of cyclin D1 enhances gene amplification.Cancer Res. 1996 Jan 1;56(1):36-9. Cancer Res. 1996. PMID: 8548770
-
Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma.Mod Pathol. 1996 Jul;9(7):725-30. Mod Pathol. 1996. PMID: 8832554 Review.
-
Relevance of cyclin D1 and other molecular markers to cancer chemoprevention.J Cell Biochem Suppl. 1996;25:23-8. J Cell Biochem Suppl. 1996. PMID: 9027594 Review.
Cited by
-
Ovarian cancer.Annu Rev Pathol. 2009;4:287-313. doi: 10.1146/annurev.pathol.4.110807.092246. Annu Rev Pathol. 2009. PMID: 18842102 Free PMC article. Review.
-
New insights on the role of hormonal therapy in ovarian cancer.Steroids. 2013 Jun;78(6):530-7. doi: 10.1016/j.steroids.2013.01.008. Epub 2013 Feb 8. Steroids. 2013. PMID: 23402742 Free PMC article. Review.
-
PI3K/Akt/JNK/c-Jun signaling pathway is a mediator for arsenite-induced cyclin D1 expression and cell growth in human bronchial epithelial cells.Curr Cancer Drug Targets. 2009 Jun;9(4):500-9. doi: 10.2174/156800909788486740. Curr Cancer Drug Targets. 2009. PMID: 19519318 Free PMC article.
-
Transfection of rat ovarian surface epithelium with erb-B2/neu induces transformed phenotypes in vitro and the tumorigenic phenotype in vivo.Am J Pathol. 1998 Jan;152(1):297-306. Am J Pathol. 1998. PMID: 9422547 Free PMC article.
-
Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer.PLoS One. 2015 Jul 24;10(7):e0132579. doi: 10.1371/journal.pone.0132579. eCollection 2015. PLoS One. 2015. PMID: 26207989 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials